BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27027402)

  • 21. LncRNA-H19 induces hepatic stellate cell activation via upregulating alcohol dehydrogenase III-mediated retinoic acid signals.
    Wang ZM; Xia SW; Zhang T; Wang ZY; Yang X; Kai J; Cheng XD; Shao JJ; Tan SZ; Chen AP; Wang SJ; Zhang F; Zhang ZL; Zheng SZ
    Int Immunopharmacol; 2020 Jul; 84():106470. PubMed ID: 32304991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guggulsterone attenuates activation and survival of hepatic stellate cell by inhibiting nuclear factor kappa B activation and inducing apoptosis.
    Kim BH; Yoon JH; Yang JI; Myung SJ; Lee JH; Jung EU; Yu SJ; Kim YJ; Lee HS; Kim CY
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1859-68. PubMed ID: 23808824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvianolic acid B lowers portal pressure in cirrhotic rats and attenuates contraction of rat hepatic stellate cells by inhibiting RhoA signaling pathway.
    Xu H; Zhou Y; Lu C; Ping J; Xu LM
    Lab Invest; 2012 Dec; 92(12):1738-48. PubMed ID: 22986787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts.
    Fickert P; Fuchsbichler A; Moustafa T; Wagner M; Zollner G; Halilbasic E; Stöger U; Arrese M; Pizarro M; Solís N; Carrasco G; Caligiuri A; Sombetzki M; Reisinger E; Tsybrovskyy O; Zatloukal K; Denk H; Jaeschke H; Pinzani M; Trauner M
    Am J Pathol; 2009 Dec; 175(6):2392-405. PubMed ID: 19910507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dihydroartemisinin inhibits the activation and proliferation of hepatic stellate cells by regulating miR‑29b‑3p.
    Huan S; Sun S; Song S; Dai J; Zhu G; Zhong Y; Ji Y; Zheng S; Yin G
    Int J Mol Med; 2023 May; 51(5):. PubMed ID: 37026504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polydatin attenuates hepatic stellate cell proliferation and liver fibrosis by suppressing sphingosine kinase 1.
    Lan T; Zhuang L; Li S; Yang G; Xuan Y; Guo J
    Biomed Pharmacother; 2020 Oct; 130():110586. PubMed ID: 34321171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis.
    Zhou J; Cui S; He Q; Guo Y; Pan X; Zhang P; Huang N; Ge C; Wang G; Gonzalez FJ; Wang H; Hao H
    Nat Commun; 2020 Jan; 11(1):240. PubMed ID: 31932588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased contractility of hepatic stellate cells in cirrhosis is mediated by enhanced Ca2+-dependent and Ca2+-sensitization pathways.
    Iizuka M; Murata T; Hori M; Ozaki H
    Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1010-21. PubMed ID: 21393429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration.
    Wang R; Ding Q; Yaqoob U; de Assuncao TM; Verma VK; Hirsova P; Cao S; Mukhopadhyay D; Huebert RC; Shah VH
    J Biol Chem; 2015 Dec; 290(52):30684-96. PubMed ID: 26534962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the SphK1/S1P signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells.
    González-Fernández B; Sánchez DI; Crespo I; San-Miguel B; Álvarez M; Tuñón MJ; González-Gallego J
    Biofactors; 2017 Mar; 43(2):272-282. PubMed ID: 27801960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
    Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PHP14 regulates hepatic stellate cells migration in liver fibrosis via mediating TGF-β1 signaling to PI3Kγ/AKT/Rac1 pathway.
    Xu A; Li Y; Zhao W; Hou F; Li X; Sun L; Chen W; Yang A; Wu S; Zhang B; Yao J; Wang H; Huang J
    J Mol Med (Berl); 2018 Feb; 96(2):119-133. PubMed ID: 29098317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dihydroartemisinin alleviates bile duct ligation-induced liver fibrosis and hepatic stellate cell activation by interfering with the PDGF-βR/ERK signaling pathway.
    Chen Q; Chen L; Kong D; Shao J; Wu L; Zheng S
    Int Immunopharmacol; 2016 May; 34():250-258. PubMed ID: 27038258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Docosahexaenoic acid inhibits hepatic stellate cell activation to attenuate liver fibrosis in a PPARγ-dependent manner.
    He J; Hong B; Bian M; Jin H; Chen J; Shao J; Zhang F; Zheng S
    Int Immunopharmacol; 2019 Oct; 75():105816. PubMed ID: 31437794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors.
    Liu Y; Saiyan S; Men TY; Gao HY; Wen C; Liu Y; Zhou X; Wu CT; Wang LS; Cui CP
    J Pathol; 2013 Aug; 230(4):365-76. PubMed ID: 23839903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition.
    Sohail MA; Hashmi AZ; Hakim W; Watanabe A; Zipprich A; Groszmann RJ; Dranoff JA; Torok NJ; Mehal WZ
    Hepatology; 2009 Jan; 49(1):185-94. PubMed ID: 18844235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. F‑actin cytoskeleton reorganization is associated with hepatic stellate cell activation.
    Cui X; Zhang X; Yin Q; Meng A; Su S; Jing X; Li H; Guan X; Li X; Liu S; Cheng M
    Mol Med Rep; 2014 May; 9(5):1641-7. PubMed ID: 24626324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt/β-catenin signalling via interaction with Gli1.
    Zhang F; Wang F; He J; Lian N; Wang Z; Shao J; Ding H; Tan S; Chen A; Zhang Z; Wang S; Zheng S
    Br J Pharmacol; 2021 Jun; 178(11):2246-2265. PubMed ID: 33085791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ROS-JNK1/2-dependent activation of autophagy is required for the induction of anti-inflammatory effect of dihydroartemisinin in liver fibrosis.
    Zhang Z; Guo M; Zhao S; Shao J; Zheng S
    Free Radic Biol Med; 2016 Dec; 101():272-283. PubMed ID: 27989749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.